Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Daily
17m
Pfizer RSV Vaccine Abrysvo gets USFDA ok for high-risk adults aged 18-59
The approval for the vaccine, Abrysvo, in adults aged 18 to 59 was based on the results from a late stage trial in which two doses of the vaccine were teste ...
59m
Calluna Pharma Successfully Completes Phase 1 Clinical Study of CAL101, a First-in-Class Therapeutic for Fibrotic and Fibro-Inflammatory Indications
Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Linked to E. coli outbreak
Arrested in trafficking case
To appear on Rogan podcast
Arlington visit records order
MO court upholds release
Lake Erie toxic algae study
To close 150 locations
2 US troops injured in raid
Trespassing charge upheld
Veteran film producer dies
Giant ‘ghost’ fish spotted
Six indicted for fraud in Ohio
Brain stimulation study
FAA finalizes safety rules
DOJ alleges racial bias
FDA approves RSV vaccine
GA election rules appeal
SK mulls arms for Ukraine
Target to cut prices
Raises US growth forecast
Hospitals' IV fluid shortage
Ordered to hand over assets
Same-day pharmacy delivery
2025 Medicare changes
Probing leak of US intel
To headline 2 Harris rallies
Infant mortality increased
US semiconductor tax credit
Right whale population rises
Reveals 2025 tax brackets
Related topics
Pfizer
Food and Drug Administration
Merck & Co.
Feedback